Founded in 2019, Truemeds operates in Health Tech industry. Initially focusing on direct-to-consumer medication delivery, the company has broadened its services to include generic and branded medicati...
Funding stage:
Series C
Last funding:
10/08/2025
Total funding:
$176.47 Mn+
Revenue:
Investors
Employee count:
1,302
Last 90d
1,302
Last 90d
Web traffic:
4.8 Mn
4.8 Mn
Last 30d
Last 30d
Glassdoor Rating:
Truemeds: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders58
Latest Filing Date29 June 2025- Funding Events21
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Truemeds
As of 30 June 2025, Truemeds's equity is held by 56 shareholders, with the top three being WestBridge AIF - I, Info Edge Venture Fund I, and Kunal Nalin Wani.
WestBridge AIF - I holds the largest stake in Truemeds at 25.1% as of 30 June 2025.
As of 30 June 2025, founders collectively hold 22.1% equity in Truemeds.
As of 30 June 2025, investors collectively hold 72.3% equity in Truemeds.
Truemeds's ESOP pool stands at 4.5% of total equity as of 30 June 2025.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links